Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Adult's Warm Auto-Immune Hemolytic Anemia
NCT01181154Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2011
- Primary completion
- Jan 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in warm autoimmune hemolytic anemia (wAIHA) comparing Rituximab + Prednisone with Placebo + Prednisone (2 arms). Primary endpoint: Overall Response Rate (Complete and Partial Response) at 1 year. Started Mar 2011; status: completed.
02
Drugs
rituximab
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT01181154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181154.